Two-point immobilization of M3 muscarinic receptor: a method for recognizing receptor antagonists in natural products

被引:0
|
作者
Huang, Xiaomin [1 ]
Wang, Ting [1 ]
Wang, Ludan [1 ]
Sun, Yantao [1 ]
Zhang, Ziru [1 ]
Zhang, Yajun [1 ]
机构
[1] Northwest Univ, Minist Educ, Minist Life Sci & Med, Key Lab Resource Biol & Biotechnol Western China, Xian 710069, Peoples R China
基金
中国国家自然科学基金;
关键词
Biochromatography; Immobilized M3 muscarinic receptors; BJ-PRO-13a peptide; Drug discovery; Natural products; NONCOMPETITIVE INHIBITORS; SNAKE-VENOM; PROTEIN; CHROMATOGRAPHY; DISCOVERY; MACHR;
D O I
10.1186/s13065-024-01198-z
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In the investigation of active ingredients from natural products, current technologies relying on drug-target affinity recognition analysis face significant challenges. This is primarily due to their limited specificity and inability to provide downstream pharmacodynamic information, such as agonistic or antagonistic activity. In this study, a two-point method was developed by immobilizing M3 acetylcholine receptor (M3R) through the combination of the conformation-specific peptide BJ-PRO-13a and the HaloTag trap system. We systematically assessed the specificity of the immobilized M3R using known M3R antagonists (pirenzepine and atropine) and agonists (cevimeline and pilocarpine). By frontal analysis and nonlinear chromatography, the performance of immobilized M3R was evaluated in terms of binding kinetics and thermodynamics of four drugs to the immobilized M3R. Additionally, we successfully identified two M3R antagonists within an extract from Daturae Flos (DF), specifically hyoscyamine and scopolamine. Our findings demonstrate that this immobilization method effectively captures receptor-ligand binding interactions and can discern receptor agonists from antagonists. This innovation enhances the efficiency of receptor chromatography to determine binding-affinity in the development of new drugs, offering promise for the screening and characterization of active compounds, particularly within complex natural products.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Synthesis and optimization of novel and selective muscarinic M3 receptor antagonists
    Kumar, Naresh
    Kaur, Kirandeep
    Aeron, Shelly
    Dharmarajan, Sankaranarayanan
    Silamkoti, Arun D. V.
    Mehta, Anita
    Gupta, Suman
    Chugh, Anita
    Gupta, Jang B.
    Salman, Mohammad
    Palle, Venkata P.
    Cliffe, Ian A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5256 - 5260
  • [2] Long-acting muscarinic M3 receptor antagonists -: GlaxoSmithKline
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (09) : 1315 - 1320
  • [3] Analogues of oxybutynin as M3 selective muscarinic receptor antagonists.
    Sarma, PKS
    Kumar, N
    Kaur, K
    Chugh, A
    Gupta, S
    Dutt, A
    Gupta, JB
    Mehta, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U58 - U59
  • [4] Long-acting muscarinic M3 receptor antagonists -: Theravance
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (09) : 1321 - 1326
  • [5] Discovery of long acting inhaled muscarinic M3 receptor antagonists
    Baettig, Urs
    Collingwood, Steve
    Janus, Diana
    Devereux, Nick
    Stanley, Emily
    Cox, Brian
    McCarthy, Clive
    Charlton, Steven
    Leighton-Davis, Juliette
    Fozard, John R.
    Baur, Francois
    Farr, Dave
    Mazzoni, Lazzaro
    Patel, Viral
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 750 - 750
  • [6] Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations
    Galvani, Francesca
    Pala, Daniele
    Cuzzolin, Alberto
    Scalvini, Laura
    Lodola, Alessio
    Mor, Marco
    Rizzi, Andrea
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (09) : 2842 - 2856
  • [7] At physiological concentrations, deoxycholic acid conjugates are M3 muscarinic receptor antagonists
    Raufman, JP
    Chen, Y
    Zimniak, P
    GASTROENTEROLOGY, 2001, 120 (05) : A357 - A358
  • [8] Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor
    Dowling, Mark R.
    Charlton, Steven J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (07) : 927 - 937
  • [9] A review of the pharmacokinetics of M3 muscarinic receptor antagonists used for the treatment of asthma
    Matera, Maria Gabriella
    Rinaldi, Barbara
    Berardo, Carmela
    Rinaldi, Michele
    Cazzola, Mario
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (02) : 143 - 148
  • [10] Discovery of Novel Potent Muscarinic M3 Receptor Antagonists with Proper Plasma Stability by Structural Recombination of Marketed M3 Antagonists
    Xiang, Zuojuan
    Liu, Jun
    Sun, Hongbin
    Wen, Xiaoan
    CHEMMEDCHEM, 2017, 12 (15) : 1173 - 1182